Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > 1b results?
View:
Post by SS1316 on Jul 26, 2022 7:01pm

1b results?

Is there an estimated timeline for the 1b results?
Comment by jfm1330 on Jul 26, 2022 7:49pm
On clinicaltrials.gov the estimated study completion date is March 2023, but they should have interim results before that if they get something clearly positive. https://clinicaltrials.gov/ct2/show/NCT04706962?term=th1902&draw=2&rank=1
Comment by SS1316 on Jul 26, 2022 8:12pm
Cheers, thanks.
Comment by LouisW on Jul 26, 2022 10:07pm
The release of data was mentioned in the closing remark of 2022 Q2 meeting. Below is the excerpt. From my perspective, the interim data will be likely released prior to 2022Q3 meeting which will be held in mid October, so they can talk about it on the meeting. The second important takeaway is that we have successfully reached the end of the dose escalation portion in TH1902, and have established ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities